Analysis of different HER ‐2 mutations in breast cancer progression and drug resistance
Author:
Affiliation:
1. Department of Medical Oncology Jinling Hospital Medical School of Nanjing University Nanjing China
2. Department of Medical Oncology Jinling Hospital School of Medicine Southern Medical University Guangzhou China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12662
Reference110 articles.
1. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
2. The c-erbB-2 Protein in Oncogenesis: Molecular Structure to Molecular Epidemiology
3. Atomistic Insights into Regulatory Mechanisms of the HER2 Tyrosine Kinase Domain: A Molecular Dynamics Study
4. Cell Signaling by Receptor Tyrosine Kinases
5. Intragenic ERBB2 kinase mutations in tumours
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy;Oncology;2023-09-05
2. Computational Engineering of a Therapeutic Antibody to Inhibit Multiple Mutants of HER2 Without Compromising Inhibition of the Canonical HER2;2023-07-25
3. Efficacy of anti-HER2 drugs in the treatment of patients with HER2-mutated cancers: a systematic review and meta-analysis;Clinical and Experimental Medicine;2023-04-30
4. The role of next‐generation sequencing in the examination of signaling genes in Brca1/2 ‐negative breast cancer cases;Annals of Human Genetics;2022-12-07
5. Novel markers in breast pathology;Histopathology;2022-12-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3